Medistim is a Norwegian medical device company that develops and sells systems for intraoperative quality control in cardiac and vascular surgery. Its devices use transit-time flow measurement and ultrasound imaging to verify blood flow and confirm the success of bypass procedures.
Date confirmed from the company's financial calendar filed with the Oslo exchange (Newsweb).
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medistim is scheduled to report its next quarterly earnings on 10/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medistim last reported quarterly earnings on 8/21/2026 (Q2 2026). Earnings per share (EPS) came in at 2.66 NOK.
Across its last 4 earnings reports, Medistim stock moved by ±4.2% on average the following day. The largest reaction was +6.5% on 02/27/2026; 3 of 4 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.